Explore all the latest information in lymphoma and CLL, arranged by key congresses and meetings. Listed below are recently updated congresses and meetings.
5-year results of the MURANO phase III trial of venetoclax + rituximab vs bendamustine + rituximab in patients with CLL
During the 62nd American Society of Hematology (ASH) Annual Meeting and...
NCCN recommendation of zanubrutinib as first-line and second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma
On December 3, 2020, the National Comprehensive Cancer Network...
What factors guide treatment decisions in the frontline treatment of follicular lymphoma?
During the European School of Haematology (ESH)'s 2nd How to Diagnose & Treat Lymphoma conference, the...
Genetic dysregulation of B-cell lymphoma: A focus on epigenetic modifiers in DLBCL and FL from ESH 2020
The majority of lymphomas originate from B cells undergoing neoplastic changes (90–95%) and...
Satellite Symposium | Patient with R/R CLL—Latin American perspective
The virtual Lymphoma Hub Satellite Symposium, at the European School of Haematology (ESH) ‘2nd How to Diagnose and Treat:...
Satellite Symposium | Patient with R/R CLL—European perspective
The virtual Lymphoma Hub Satellite Symposium, at this year's European School of Haematology (ESH) ‘2nd How to Diagnose and Treat:...
ASCEND final results: Acalabrutinib compared with idelalisib + R or Bendamustine + R in R/R CLL
Summary of the 6-month follow up of the phase III ASCEND trial as presented at SOHO 2020.
Lymphodepletion optimization for CAR T-cell therapy
A summary of the talk by Elizabeth Budde at the eighth annual meeting of the SOHO regarding the optimization of lymphodepletion protocols.
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
ASH: Lymphoma Biology
ASH: Lymphoma Biology 2018
European Hematology Association
European Lymphoma Institute Workshop
ELI Workshop 2019
European School of Haematology
European Society for Blood and Marrow Transplantation
International Conference on Malignant Lymphoma
International Workshop on Chronic Lymphocytic Leukemia
EHA–EBMT CAR T Meeting 2020
Society of Hematologic Oncology